Table 2 Decrease in DAS28 and components at follow-up compared to baseline for each individual patient

6 months, mean (SD)

n=315

n=443

 DAS28

1.6 (1.7)

1.5 (1.5)

 Swollen joint count (0–28)

3.9 (5.1)

3.9 (4.8)

 Tender joint count (0–28)

4.1 (6.7)

4.0 (6.7)

 ESR mm/h

9.3 (23.0)

8.0 (16.1)

 Patient global assessment (0–10)

2.1 (3.4)

1.8 (3.1)

12 months, mean (SD)

n=280

n=398

 DAS28

1.9 (1.8)

1.9 (1.7)

 Swollen joint count (0–28)

4.3 (5.2)

4.3 (5.1)

 Tender joint count (0–28)

4.8 (6.9)

4.8 (6.9)

 ESR mm/h

11.8 (23.5)

10.3 (17.8)

 Patient global assessment (0–10)

2.2 (3.3)

2.2 (3.3)

18 months, mean (SD)

n=239

n=352

 DAS28

1.9 (1.8)

1.8 (1.7)

 Swollen joint count (0–28)

4.3 (5.3)

4.0 (5.4)

 Tender joint count (0–28)

4.8 (7.0)

4.5 (6.8)

 ESR mm/h

12.5 (23.1)

10.2 (17.8)

 Patient global assessment (0–10)

2.3 (3.3)

2.2 (3.3)

24 months, mean (SD)

n=208

n=301

 DAS28

2.3 (1.8)

1.9 (1.7)

 Swollen joint count (0–28)

5.1 (5.5)

4.5 (5.3)

 Tender joint count (0–28)

6.0 (7.3)

4.9 (7.5)

 ESR mm/h

15.7 (25.4)

10.9 (18.7)

 Patient global assessment (0–10)

2.5 (3.3)

2.0 (3.2)